Product List | Takeda U.S.
U.S. Product List
Committed to better health for individuals, Takeda in the U.S. markets innovative pharmaceutical treatments. To learn more about our oncology products, visit www.takedaoncology.com. Click on the product links for more detailed information on our other U.S. marketed products.
In addition to our on-the-market products, Takeda invests in an active R&D pipeline in an effort to bring new treatments to patients in need. Click here for more information on our global R&D pipeline. Click here to learn more about our pricing philosophy.
ACTOS (pioglitazone)
ACTOplus met (pioglitazone and metformin HCl)
ADDERALL XR® (mixed salts of a single-entity amphetamine)
ADVATE® [Antihemophilic Factor (Recombinant)]
ADYNOVATE® [Antihemophilic Factor (Recombinant), PEGylated]
ADZYNMA (ADAMTS13, recombinant-krhn)
AGRYLIN® (anagrelide hydrochloride)
AMITIZA (lubiprostone)